Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026850 (
muscular dystrophy
)
5,870
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Matrix metalloproteinases (MMPs), a family of endopeptidases that are involved in the degradation of extracellular matrix components, have been implicated in skeletal muscle regeneration. Among the MMPs, MMP-2 and MMP-9 are upregulated in Duchenne muscular dystrophy (DMD), a fatal X-linked muscle disorder. However, inhibition or overexpression of specific MMPs in a mouse model of DMD (mdx) has yielded mixed results regarding disease progression, depending on the MMP studied. Here, we have examined the role of
MMP-10
in muscle regeneration during injury and
muscular dystrophy
. We found that skeletal muscle increases
MMP-10
protein expression in response to damage (notexin) or disease (mdx mice), suggesting its role in muscle regeneration. In addition, we found that
MMP-10
-deficient muscles displayed impaired recruitment of endothelial cells, reduced levels of extracellular matrix proteins, diminished collagen deposition, and decreased fiber size, which collectively contributed to delayed muscle regeneration after injury. Also,
MMP-10
knockout in mdx mice led to a deteriorated dystrophic phenotype. Moreover,
MMP-10
mRNA silencing in injured muscles (wild-type and mdx) reduced muscle regeneration, while addition of recombinant human
MMP-10
accelerated muscle repair, suggesting that
MMP-10
is required for efficient muscle regeneration. Furthermore, our data suggest that
MMP-10
-mediated muscle repair is associated with VEGF/Akt signaling. Thus, our findings indicate that
MMP-10
is critical for skeletal muscle maintenance and regeneration during injury and disease.
...
PMID:MMP-10 is required for efficient muscle regeneration in mouse models of injury and muscular dystrophy. 2412 96